IGC Pharma, Inc.
Data quality: 100%
IGC
NYSE
Manufacturing
Chemicals
$0.32
▲
$0.00
(0.31%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-0.82%
Growth
Revenue Growth (5Y)
-0.82%
Below sector avg (1.82%)
Revenue (1Y)-35.39%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-48.99%
Above sector avg (-54.47%)
ROIC-91.75%
Net Margin-493.04%
Op. Margin-1192.19%
Safety
Debt / Equity
0.02
Below sector avg (0.30)
Current Ratio1.32
Interest Coverage-2797.67
Valuation
PE (TTM|NTM)
-8.12 | -3.76
Below sector avg (-1.50)
P/B Ratio3.48
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -0.82% annually over 5 years
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -5.49 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 34.57%
Capital efficient — spends only 2.70% of revenue on capex
Price History
Financial Trends
Analyst Price Target
2 analysts
Buy
+1185.0%
upside to target
Current
$0.32
Consensus Target
$4.13
$3.00
Low
$5.25
High
Forecast
Forward P/E
-3.76
Forward EPS
-$0.09
Est. Revenue
1.03 M
Earnings Surprises
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -$0.02
·
Rev Est: 198,000.0
| Q22024 | Q32024 | Q42024 | 2026-Q1 | 2026-Q2 | Q12025 | Q22025 | Q32025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported | -$0.03 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$0.01 | -$0.02 | -$0.02 | — | — |
| Estimate | -$0.03 | -$0.03 | -$0.03 | -$0.02 | -$0.02 | -$0.02 | -$0.03 | -$0.02 | -$0.02 | -$0.02 |
| Surprise | 0.00% | +33.33% | +33.33% | 0.00% | 0.00% | +50.00% | +20.00% | 0.00% | — | — |
Growth
Rev 5Y: -0.82% · Earnings 1Y: N/A
Growth
Rev 5Y: -0.82% · Earnings 1Y: N/A| Revenue Growth (1Y) | -35.39% | Revenue Growth (3Y) | -2.33% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0.82% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -48.99% · Net Margin: -493.04%
Profitability
ROE: -48.99% · Net Margin: -493.04%| Revenue (TTM) | 704,000.0 | Net Income (TTM) | -3.47 M |
| ROE | -48.99% | ROA | -39.25% |
| Gross Margin | 26.85% | Operating Margin | -1192.19% |
| Net Margin | -493.04% | Free Cash Flow (TTM) | -5.49 M |
| ROIC | -91.75% | FCF Growth (3Y) | N/A |
Safety
D/E: 0.02 · Current: 1.32
Safety
D/E: 0.02 · Current: 1.32| Debt / Equity | 0.02 | Current Ratio | 1.32 |
| Interest Coverage | -2797.67 | Asset Turnover | 0.08 |
| Working Capital | 490,000 | Tangible Book Value | 3.21 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -8.12 · EV/EBITDA: N/A
Valuation
P/E: -8.12 · EV/EBITDA: N/A| P/E Ratio | -8.12 | Forward P/E | -3.76 |
| P/B Ratio | 3.48 | P/S Ratio | 40.05 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 27.38 | Fwd Earnings Yield | N/A |
| FCF Yield | -19.46% | ||
| Market Cap | 28.20 M | Enterprise Value | 27.23 M |
Per Share
EPS: -0.03 · FCF/Share: -0.06
Per Share
EPS: -0.03 · FCF/Share: -0.06| EPS (Diluted TTM) | -0.03 | Revenue / Share | 0.01 |
| FCF / Share | -0.06 | OCF / Share | -0.06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 158.11% · CapEx/Rev: 2.70%
Efficiency
FCF Conv: 158.11% · CapEx/Rev: 2.70%| CapEx / Revenue | 2.70% | FCF Conversion | 158.11% |
| SBC-Adj. FCF | -14.49 M | Growth Momentum | -34.57 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 869,000.0 | 1.35 M | 911,000.0 | 397,000.0 | 898,000.0 |
| Net Income | -4.15 M | -13.00 M | -11.51 M | -15.02 M | -8.81 M |
| EPS (Diluted) | -0.05 | — | — | — | — |
| Gross Profit | 297,000.0 | 733,000.0 | 442,000.0 | 194,000.0 | 113,000.0 |
| Operating Income | -7.75 M | -9.80 M | -11.57 M | -15.43 M | -8.72 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 3.92 M | 3.77 M | 3.46 M | 2.33 M | 929,000.0 |
| SG&A Expenses | 4.12 M | 6.76 M | 8.55 M | 13.29 M | 7.91 M |
| D&A | 324,000.0 | 637,000.0 | 657,000.0 | 651,000.0 | 478,000.0 |
| Interest Expense | 4,000.0 | 5,000.0 | 5,000.0 | 5,000.0 | 3,000.0 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9.71 M | 9.90 M | 17.18 M | 26.83 M | 35.87 M |
| Total Liabilities | 2.29 M | 2.58 M | 2.27 M | 2.94 M | 3.06 M |
| Shareholders' Equity | 7.42 M | 7.32 M | 14.91 M | 23.89 M | 32.80 M |
| Total Debt | 134,000.0 | 140,000.0 | 144,000.0 | 147,000.0 | 580,000.0 |
| Cash & Equivalents | 900,000.0 | 1.20 M | 3.20 M | 10.46 M | 14.55 M |
| Current Assets | 1.79 M | 3.71 M | 6.47 M | 15.11 M | 23.52 M |
| Current Liabilities | 2.16 M | 2.34 M | 1.90 M | 2.44 M | 2.37 M |
Peer Comparison
vs Manufacturing sector median (1605 peers)
Compared with similar companies in Manufacturing
Peer Comparison
vs Manufacturing sector median (1605 peers) Compared with similar companies in Manufacturing| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.1 | -1.5 |
| P/B | 3.5 | 1.6 |
| ROE % | -49.0 | -54.5 |
| Net Margin % | -493.0 | -41.5 |
| Rev Growth 5Y % | -0.8 | 1.8 |
| D/E | 0.0 | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"IGC","listing_kind":"stock","pathname":"/stocks/igc","exchange":"NYSE","country":"US"}}